Patents by Inventor Juan B. Gonzalez

Juan B. Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
    Publication number: 20230248650
    Abstract: The invention is directed to a composition comprising cromolyn sodium and ibuprofen, wherein the cromolyn sodium is micronized and the cromolyn sodium and ibuprofen are present in a weight ratio of 1:1-2. In one embodiment, the ibuprofen is passed through a sieve, such as a 300 ?m sieve and to methods of making the same.
    Type: Application
    Filed: September 7, 2022
    Publication date: August 10, 2023
    Inventors: David R. Elmaleh, Juan B. Gonzalez
  • Powdered formulations of cromolyn sodium and alpha-lactose
    Patent number: 11291648
    Abstract: The present disclosure is directed to a composition comprising micronized cromolyn sodium, ?-lactose, and a salt of fatty acid, wherein the ?-lactose has a particle size distribution of D90 of 45-70 ?m, D50 of 10-35 ?m, and D10 of 2-13 ?m. The present disclosure is also directed to a method of treating Alzheimer's disease, amyloidosis-associated condition (AAC), traumatic brain injury, Huntington's disease, atherosclerosis, cytokine release syndrome (CRS), dementia, head injury, infection, neuroinflammation, prion disease, stroke, amyotrophic lateral sclerosis (ALS), Parkinson's disease, or asthma using the composition.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: April 5, 2022
    Assignees: The General Hospital Corporation, AZTherapies, Inc.
    Inventors: David R. Elmaleh, Juan B. Gonzalez
  • POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
    Publication number: 20210023010
    Abstract: The invention is directed to a composition comprising cromolyn sodium and ibuprofen, wherein the cromolyn sodium is micronized and the cromolyn sodium and ibuprofen are present in a weight ratio of 1:1-2. In one embodiment, the ibuprofen is passed through a sieve, such as a 300 ?m sieve and to methods of making the same.
    Type: Application
    Filed: February 13, 2020
    Publication date: January 28, 2021
    Inventors: David R. Elmaleh, Juan B. Gonzalez
  • Powdered formulations of cromolyn sodium and ibuprofen
    Patent number: 10561612
    Abstract: The invention is directed to a composition comprising cromolyn sodium and ibuprofen, wherein the cromolyn sodium is micronized and the cromolyn sodium and ibuprofen are present in a weight ratio of 1:1-2. In one embodiment, the ibuprofen is passed through a sieve, such as a 300 ?m sieve and to methods of making the same.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: February 18, 2020
    Assignees: The General Hospital Corporation, AZTherapies, Inc.
    Inventors: David R. Elmaleh, Juan B. Gonzalez
  • POWDERED FORMULATIONS OF CROMOLYN SODIUM AND ALPHA-LACTOSE
    Publication number: 20200022947
    Abstract: The present disclosure is directed to a composition comprising micronized cromolyn sodium, ?-lactose, and a salt of fatty acid, wherein the ?-lactose has a particle size distribution of D90 of 45-70 ?m, D50 of 10-35 ?m, and D10 of 2-13 ?m. The present disclosure is also directed to a method of treating Alzheimer's disease, amyloidosis-associated condition (AAC), traumatic brain injury, Huntington's disease, atherosclerosis, cytokine release syndrome (CRS), dementia, head injury, infection, neuroinflammation, prion disease, stroke, amyotrophic lateral sclerosis (ALS), Parkinson's disease, or asthma using the composition.
    Type: Application
    Filed: September 27, 2019
    Publication date: January 23, 2020
    Inventors: David R. Elmaleh, Juan B. Gonzalez
  • POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
    Publication number: 20190022006
    Abstract: The invention is directed to a composition comprising cromolyn sodium and ibuprofen, wherein the cromolyn sodium is micronized and the cromolyn sodium and ibuprofen are present in a weight ratio of 1:1-2. In one embodiment, the ibuprofen is passed through a sieve, such as a 300 ?m sieve and to methods of making the same.
    Type: Application
    Filed: December 12, 2017
    Publication date: January 24, 2019
    Applicant: AZTherapies, Inc.
    Inventors: David R. ELMALEH, Juan B. Gonzalez